Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Conleth G Murphy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Irish Journal of Medical Science|April 13, 2022
Breast cancer outcomes in a private hospital appear better than national outcomes in a country with a mixed public/private healthcare modelMichael Killian, Deirdre O' Mahony, Kate Murphy, et al.
Journal of Clinical Nursing|August 15, 2019
Cancer-related fatigue and self-care agency: A multicentre survey of patients receiving chemotherapyPatricia O'Regan, Geraldine McCarthy, Seamus O'Reilly, et al.
Cancer Medicine|April 28, 2015
Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significancePaul Ryan, Heidi Furlong, Conleth G Murphy, et al.
Cancer|November 17, 2011
Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancerConleth G Murphy, Divya Mallam, Samantha Stein, et al.
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Neuro-Oncology|July 13, 2014
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective studyAki Morikawa, David M Peereboom, Helen R Thorsheim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2023
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA StudyUrsula A Matulonis, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Irish Journal of Medical Science|April 13, 2022
Breast cancer outcomes in a private hospital appear better than national outcomes in a country with a mixed public/private healthcare modelMichael Killian, Deirdre O' Mahony, Kate Murphy, et al.
Journal of Clinical Nursing|August 15, 2019
Cancer-related fatigue and self-care agency: A multicentre survey of patients receiving chemotherapyPatricia O'Regan, Geraldine McCarthy, Seamus O'Reilly, et al.
Cancer Medicine|April 28, 2015
Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significancePaul Ryan, Heidi Furlong, Conleth G Murphy, et al.
Cancer|November 17, 2011
Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancerConleth G Murphy, Divya Mallam, Samantha Stein, et al.
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Neuro-Oncology|July 13, 2014
Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective studyAki Morikawa, David M Peereboom, Helen R Thorsheim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2023
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA StudyUrsula A Matulonis, Domenica Lorusso, Ana Oaknin, et al.
Gynecologic Oncology|October 26, 2024
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summaryKathleen N Moore, Domenica Lorusso, Ana Oaknin, et al.
Pageof 2